April 16th 2025
The new firm—with 13 manufacturing facilities spanning France, Sweden, and Spain—will support the pharma supply chain through to commercialization.
March 12th 2025
The partnership focuses on enhancing the patient experience by providing greater affordability and access to specialty meds.
February 24th 2025
The injection for the treatment of psoriatic arthritis—among other indications—is a biosimilar to Stelara.
February 6th 2025
A look at the actionable steps needed to elicit change.
January 27th 2025
Known as AVT05, the Alvotech medication is a proposed biosimilar to Simponi, prescribed to treat various inflammatory conditions.
Newron, Myung In Pharm Form Partnership Centered Around Treating Schizophrenia in South Korea
The license agreement will feature an upcoming Phase III trial and—depending on results—the development, manufacturing, and commercialization of evenamide as a potential treatment option.
J&J Inks $14.6 Billion Intra-Cellular Therapies Deal
The acquisition features Caplyta as part of its neuroscience portfolio, which is considered the only FDA-approved treatment for bipolar I and II depression as a monotherapy and adjunctive treatment.